Search

everythinglearnresearchcommunity

for

Search:↓

17-β estradiol and prednisolone may speed up hair regrowth after chemotherapy.

Cialis and Finasteride could be repurposed to treat aggressive melanoma.

Perhexiline can effectively target ovarian cancer cells left after treatment.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

A botanical extract may help manage hair loss from chemotherapy by preventing cell death in hair follicles.

Cancer treatments can cause hair loss, but it is often reversible and can be managed with scalp cooling and support.

Cyproterone acetate is used for topical treatment of diseases dependent on male hormones.

Scalp cooling may be less effective for women of color on certain chemotherapy treatments.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

The new drug delivery system effectively targets lung cancer cells.

Cyproterone acetate improves skin symptoms and quality of life in women with androgen-related issues.

Adriamycin and ifosfamide together work best for advanced soft tissue sarcomas.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Cinobufacin with chemotherapy improves treatment response and quality of life in advanced breast cancer patients while reducing some side effects.

TCDD changes skin cell growth and keratin production in mice.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

YH0618 helps reduce chemotherapy-induced hair loss by targeting specific proteins and pathways.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Prostaglandins may protect hair follicles during chemotherapy.

Guilu Erxian Glue may help reduce chemotherapy side effects like weight loss and heart stress.

Bendamustine combined with tucidinostat may effectively treat adult T-cell leukemia.

Diane is effective for treating acne, seborrhoea, androgenic alopecia, and mild hirsutism in women.

Early intervention and tailored management are crucial for skin side effects in cancer treatments.

Eliminating senescent cells can prevent and reverse chemotherapy-induced peripheral neuropathy.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Tofacitinib may effectively treat folliculitis decalvans.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

Triptolide effectively and safely reduces actinic keratosis lesions in mice.

Valproic acid helps delay hair loss and increases survival time for high-grade glioma patients undergoing radiation therapy.

Antiandrogen therapy helped increase hair growth in women with hormonal imbalances related to baldness.